About
Technology
Issues
FAQ
Links
Official Page
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.